| __timestamp | AstraZeneca PLC | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5579000000 | 241751000 |
| Thursday, January 1, 2015 | 5997000000 | 322292000 |
| Friday, January 1, 2016 | 5890000000 | 344320000 |
| Sunday, January 1, 2017 | 5757000000 | 374644000 |
| Monday, January 1, 2018 | 5932000000 | 414604000 |
| Tuesday, January 1, 2019 | 5958000000 | 466000000 |
| Wednesday, January 1, 2020 | 5991000000 | 535000000 |
| Friday, January 1, 2021 | 9736000000 | 643000000 |
| Saturday, January 1, 2022 | 9762000000 | 833000000 |
| Sunday, January 1, 2023 | 10935000000 | 899625000 |
| Monday, January 1, 2024 | 13583000000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, AstraZeneca PLC has consistently outpaced Ionis Pharmaceuticals, Inc. in R&D investment. From 2014 to 2023, AstraZeneca's R&D expenses surged by nearly 96%, peaking at approximately $10.9 billion in 2023. In contrast, Ionis Pharmaceuticals, while showing a steady increase, reached around $900 million in the same year, marking a 272% growth from 2014.
This strategic focus on R&D underscores AstraZeneca's robust pipeline and its dedication to pioneering new treatments. Meanwhile, Ionis, with its specialized focus, continues to make significant strides in its niche. As the pharmaceutical industry evolves, these investments highlight the companies' long-term vision and their roles in shaping the future of healthcare.
R&D Spending Showdown: AstraZeneca PLC vs Gilead Sciences, Inc.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Neurocrine Biosciences, Inc.
Research and Development Expenses Breakdown: AstraZeneca PLC vs Alpine Immune Sciences, Inc.
R&D Insights: How AstraZeneca PLC and TG Therapeutics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Wave Life Sciences Ltd.
Bristol-Myers Squibb Company or Ionis Pharmaceuticals, Inc.: Who Invests More in Innovation?
Incyte Corporation or Ionis Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Grifols, S.A. vs Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and CRISPR Therapeutics AG
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc.
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and HUTCHMED (China) Limited